Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits. . . . → Read More: Gene Therapy Company Exploring DNA Circuit Technology
|
|||||
|
       
  |
A clinical trial shows a drug designed to reduce inflammation in autoimmune disease patients does not clearly help patients hospitalized with Covid-19 disease. . . . → Read More: Arthritis Drug Unsuccessful for Covid-19 Hospital Patients 
A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds 
A medical device company now offers a synthetic tissue implant for torn rotator cuff, a common sports injury, designed at a Purdue University engineering lab. . . . → Read More: Univ. Lab Develops, Licenses Sports Injury Implant 
A developer of vaccines, including a leading Covid-19 vaccine, and cancer immunotherapies, is raising $168 million in its second venture round. . . . → Read More: Vaccine Spin-Off Raises $168 Million in New Funds  Comments are closed  Finance  biomedical, biotechnology, cancer, clinical trials, Covid-19, equity, investment, licensing, life sciences, pharmaceuticals, U.K., university, venture capital 
A clinical trial is underway testing a new Covid-19 vaccine based on messenger RNA, developed by biotech company Translate Bio and drug maker Sanofi. . . . → Read More: New Covid-19 mRNA Vaccine Trial Begins 2 comments - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, clinical trials, Covid-19, Europe, genomics, licensing, life sciences, pharmaceuticals 
An international consortium is funding a vaccine to prevent increasingly resistant Staphylococcus aureus infections found in health care facilities. . . . → Read More: Carb-X Funds Vaccine Against Resistant Staph Infections Comments are closed Finance, New products biomedical, biotechnology, grant, health care, licensing, life sciences, pharmaceuticals, preclinical, university 
A clinical trial is underway testing an immunotherapy for several types of stubborn solid tumor cancer, based on research in university labs. . . . → Read More: Multiple Solid-Tumor Immunotherapy Trial Underway One comment - (Comments are closed) New products biomedical, biotechnology, cancer, clinical trials, entrepreneurs, licensing, life sciences, pharmaceuticals, university 
Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease. . . . → Read More: Immune Response Shown in Alzheimer’s Vaccine Comments are closed New products biomedical, biotechnology, clinical trials, Europe, licensing, life sciences, pharmaceuticals 
Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, genomics, investment, licensing, life sciences, pharmaceuticals, university |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||